Immunome IMNM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$224.59M-5.7% | -$212.39M+4.6% | -$222.74M-4.9% | -$212.39M-3.5% | -$205.11M+30.0% | ||
| $2.46M-0.3% | $2.47M+7.8% | $2.29M+8.4% | $2.11M+4.4% | $2.02M+29.0% | ||
| $27.94M+8.8% | $25.69M+10.4% | $23.27M+8.7% | $21.41M+11.0% | $19.29M+22.5% | ||
| -$196.5M-2.9% | -$190.92M-3.2% | -$185.03M-3.5% | -$178.68M-17.0% | -$152.68M-37.8% | ||
| $9.02M-6.8% | $9.69M+42.2% | $6.81M-5.8% | $7.24M-16.6% | $8.67M+20.9% | ||
| —— | —— | —— | —— | —— | ||
| $47.7M-26.4% | $64.8M— | —— | —— | —— | ||
| $478.05M-25.4% | $640.41M+181% | $227.7M+24.7% | $182.62M-0.4% | $183.31M-23.8% | ||
| —— | —— | —— | —— | —— | ||
| -$205.52M-2.5% | -$200.6M-4.6% | -$191.84M-3.2% | -$185.92M-15.2% | -$161.35M-36.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Immunome's cash flow data come from?
- Every line is extracted from Immunome's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.